Series C funding round for Antiva Biosciences raising $22M in March 2017
Series C funding round for Antiva Biosciences raising $22M in March 2017
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
| Venture Capital | — |
| Venture Capital | — |
This company has completed 5 funding rounds. Current round is highlighted.
Total Raised
$137M
Top Valuation
-
Antiva Biosciences raised $22M in a Series C round.
The round was announced on 03/01/17.